Keywords: Pfizer, Tofacitinib, Rheumatoid arthritis, USA, FDA, PDUFA date

FDA puts back action date on Pfizer's tofacitinib by three months

Article | 22 August 2012

Print This

Pfizer (NYSE: PFE), the world’s largest drugmaker by sales, yesterday revealed that the US Food and Drug Administration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in